Tevogen receives international patent publication for AI peptide prediction technology

Go back to Tevogen receives international patent publication for AI peptide prediction technology

Microsoft (MSFT) PT Raised to $613 at Citi

July 22, 2025 6:31 AM EDT

Citi analyst Tyler Radke raised the price target on Microsoft (NASDAQ: MSFT) to $613.00 (from $605.00) while maintaining a Buy rating.

The analyst comments "We reiterate our bullish view into MSFTs F4Q results, anticipating another strong quarter of positive revisions and... More